Physician profile
Nora E Chiu
NPI 1699085928
$785.75
in general payments reported to CMS, 2019-2025
18 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.46 · 2022: $311 · 2023: $227 · 2024: $112 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $135.16 | 2022 | |
| Astellas Pharma US INC | $115.72 | 2023-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $84.09 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $68.51 | 2021-2025 | Thinprep 2000 Processor, Omni Hysteroscope, Fluent Fluid Management System |
| Ethicon US, LLC | $59.09 | 2025 | Enseal, Megadyne |
| Organon LLC | $51.31 | 2022-2025 | Jada System |
| Abbvie INC. | $40.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.76 | 2023 | |
| Merck Sharp & Dohme LLC | $32.16 | 2022 | |
| Aspira Women'S Health INC | $23.79 | 2024 | Ova1 |
| Mylan Pharmaceuticals INC. | $23.69 | 2022 | |
| Avion Pharmaceuticals | $22.64 | 2023 | Balcoltra |
| Dexcom, INC. | $22.01 | 2025 | Dexcom G6 Transmitter |
| Mayne Pharma Commercial LLC | $20.77 | 2022 | |
| Shield Therapeutics INC | $15.19 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $13.82 | 2023 | Citranatal |
| Azurity Pharmaceuticals, INC. | $12.99 | 2023 | Adthyza |
| Meditrina | $9.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.